Natera Announces 2025 ESG Goals with Publication of 2021 Report
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the publication of its 2021 Environmental, Social and Governance (ESG) report detailing the company's commitment to environmental sustainability, social equity and improved access to health care. The report, which can be found here, includes the company's 2025 ESG Goals
AUSTIN, Texas, Sept. 29, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the publication of its 2021 Environmental, Social and Governance (ESG) report detailing the company's commitment to environmental sustainability, social equity and improved access to health care. The report, which can be found here, includes the company's 2025 ESG Goals.
"In pursuing our mission to deliver innovation that improves the lives of patients, it is critically important that we operate in a sustainable way," said Steve Chapman, CEO for Natera. "We're proud to issue our first ESG report, which includes specific, measurable goals to reinforce our commitment to prioritizing environmental, social and governance initiatives."
Key highlights from Natera's 2021 ESG report include:
